|
Arf6 inhibitors for the treatment of uveal melanoma
|
1R43CA192545-01A1
|
$298,731
|
MUELLER, ALAN
|
NAVIGEN, INC.
|
|
Baylor College of Medicine Cancer Center
|
2P30CA125123-09
|
$3,155,163
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-09S2
|
$112,151
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-09S3
|
$183,048
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Cancer and Other Mortality Risks in a Cohort of U.S. Radiologic Technologists
|
ZIA CP010133 - 04180
|
$1,119,312
|
Linet, Martha
|
DCEG (NCI)
|
|
Cancer Center Support Grant
|
3P30CA016058-39S1
|
$62,500
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016058-39S2
|
$60,126
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016058-39S3
|
$31,250
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA016058-39
|
$4,582,303
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA082103-17S2
|
$50,000
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-17S3
|
$124,967
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-17S4
|
$199,969
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-17S5
|
$158,600
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
5P30CA082103-17
|
$7,292,969
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant - UT Southwestern Medical Center
|
2P30CA142543-06
|
$1,615,000
|
WILLSON, JAMES
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Cancer Risk in Myotonic Dystrophy
|
ZIA CP010144 - 10568
|
$73,122
|
Gadalla, Shahinaz
|
DCEG (NCI)
|
|
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer
|
ZIA BC 011028
|
$515,773
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-46S1
|
$138,748
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-46
|
$2,578,347
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Development of anti-angiogenesis therapy targeting integrin
|
5R01CA175112-02
|
$400,331
|
LIU, ZHI-REN
|
GEORGIA STATE UNIVERSITY
|
|
DICER1-Related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural
|
ZIA CP010144 - 10548
|
$1,001,922
|
Stewart, Douglas
|
DCEG (NCI)
|
|
Discovery of chemical probes for uveal melanoma
|
5R01CA180805-03
|
$564,926
|
VAN MEIR, ERWIN
|
EMORY UNIVERSITY
|
|
DNA Repair in Human Cancer-Prone Genetic Diseases
|
ZIA BC 004517
|
$1,039,729
|
Kraemer, Kenneth
|
CCR (NCI)
|
|
Families at high risk of cancer
|
ZIA CP004410 - 08285
|
$1,104,439
|
Caporaso, Neil
|
DCEG (NCI)
|
|
Flow Cytometric Detection of Malignant Cells in Body Fluids
|
ZIC BC 011093
|
$164,422
|
Stetler-Stevenson, Maryalice
|
CCR (NCI)
|
|
Functional Analysis of the BAP1 Metastasis Suppressor Gene in Uveal Melanoma
|
5R01CA163761-04
|
$383,875
|
RAUSCHER, FRANK
|
WISTAR INSTITUTE
|
|
Hereditary cancer predisposition syndromes and uveal melanoma
|
1R21CA191943-01
|
$200,970
|
ABDEL-RAHMAN, MOHAMED
|
OHIO STATE UNIVERSITY
|
|
HIV/HPV Cancer Prevention, Treatment & Pathogenesis: Rwanda/Einstein Consortium
|
6U54CA190163-02
|
$701,198
|
ANASTOS, KATHRYN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
IMMUNOLOGICAL MODULATION OF OCULAR TUMOR METASTASES
|
5R01CA030276-33
|
$282,171
|
NIEDERKORN, JERRY
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Immunotherapy Strategies for Uveal Melanoma
|
ZIA BC 010649
|
$410,832
|
Kammula, Udai
|
CCR (NCI)
|
|
Improving the Clinical Effectiveness and Understanding of the Biophysical Basis
|
5U19CA021239-36
|
$2,495,754
|
DELANEY, THOMAS
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
INCREMENTAL SEVERABLE FUNDING FOR THE NCI AT FREDERICK
|
261200800001E
|
$205,925,847
|
HEIMBROOK, DAVID
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
Mechanisms of Action for KCN1 in the Control of Uveal Melanoma Metastasis
|
3R01CA176001-02S1
|
$48,411
|
GROSSNIKLAUS, HANS
|
EMORY UNIVERSITY
|
|
Mechanisms of Action for KCN1 in the Control of Uveal Melanoma Metastasis
|
5R01CA176001-02
|
$323,700
|
GROSSNIKLAUS, HANS
|
EMORY UNIVERSITY
|
|
Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways
|
ZIA BC 010006
|
$484,970
|
Daar, Ira
|
CCR (NCI)
|
|
Molecular Genetics of Melanoma
|
2K24CA149202-06
|
$173,086
|
TSAO, HENSIN
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
MOLECULAR PREDICTIVE TESTING IN OCULAR MELANOMA
|
5R01CA125970-10
|
$214,232
|
HARBOUR, JAMES
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene
|
ZIA BC 011038
|
$1,031,546
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Mutation Profile as Translatable Prognostic Biomarker of Uveal Melanoma
|
1R21CA181935-01A1
|
$208,800
|
GANGULY, ARUPA
|
UNIVERSITY OF PENNSYLVANIA
|
|
Novel Techniques in Nonlinear Optical Microscopy for Improving Melanoma Diagnosis
|
5F32CA168497-03
|
$57,962
|
WILSON, JESSE
|
DUKE UNIVERSITY
|
|
Regulation of Ciliogenesis and Ciliary-related signaling
|
ZIA BC 011398
|
$873,427
|
Westlake, Christopher
|
CCR (NCI)
|
|
REGULATION OF UVEAL MELANOMA CELL FATE BY THE PKC PATHWAY VIA MITF
|
1R01CA193321-01
|
$362,569
|
MITSIADES, NICHOLAS
|
BAYLOR COLLEGE OF MEDICINE
|
|
Role of Trk Receptors in the Development and Function of Non-neuronal Structures
|
ZIA BC 010391
|
$501,603
|
Tessarollo, Lino
|
CCR (NCI)
|
|
Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion
|
ZIA BC 010958
|
$484,970
|
Daar, Ira
|
CCR (NCI)
|
|
Structural Biology of GTPase Activating Proteins
|
ZIA BC 011419
|
$303,251
|
Byrd, R. Andrew
|
CCR (NCI)
|
|
THE GENETICS OF OCULAR MELANOMA
|
5R01CA161870-06
|
$403,788
|
BOWCOCK, ANNE
|
U OF L IMPERIAL COL OF SCI/TECHNLGY/MED
|
|
The GNAQ pathway as a therapeutic target in uveal melanoma
|
5R01CA142873-06
|
$310,970
|
BASTIAN, BORIS
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-07S1
|
$37,430
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
5P30CA138292-07
|
$1,560,000
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|